Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Dengue: early-phase trial registry
A small indexed set (10 trials) with no open enrollment listed right now.
Corpus placement: #1,724 of 28,707 conditions by registered trial count.
10 US clinical trials · none currently recruiting · #1,724 of 28,707 conditions by registered trial count
Dengue: 10 US clinical trials tracked, none currently recruiting.
Dengue is the subject of 10 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Allergy and Infectious Diseases (NIAID), running 6 of these trials.
Enrollment posture brief
Registry condition dengue
OPEN 0 | RECR 0% | LATE 0 | EARLY 8 | RANK #1724 | SPON 6
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Dengue has no open enrollment in this registry pull (10 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Dengue on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Dengue is recruiting below its size-band peers.
0 of 10 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Dengue research.
National Institute of Allergy and Infectious Diseases (NIAID) accounts for 6 of 10 trials (60%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Dengue trials plan to enrol fewer than 100 people.
Median target enrolment is 72 among the 10 trials that report a genuine target (sentinel values excluded). 8 of those (80%) plan for fewer than 100 participants.
-
Dengue research is mostly interventional.
9 interventional and 1 observational studies make up this index (90% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Indexed trials (enrollment closed)
10 total, page 1 of 1
Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican Blood Donors - American Red Cross
Gen-Probe, Incorporated
NCT01656174
Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine
Sanofi Pasteur, a Sanofi Company
NCT01488890
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
National Institute of Allergy and Infectious Diseases (NIAID)
NCT03641339
TDENV PIV and LAV Dengue Prime-boost Strategy
U.S. Army Medical Research and Development Command
NCT02239614
Tetravalent Chimeric Dengue Vaccine Trial
National Institute of Allergy and Infectious Diseases (NIAID)
NCT01110551
Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
National Institute of Allergy and Infectious Diseases (NIAID)
NCT01506570
Evaluation of the Safety and Efficacy of a Single Dose of a Dengue Vaccine (TV005) in Healthy Adults
National Institute of Allergy and Infectious Diseases (NIAID)
NCT02317900
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3-3'Ddelta30) in Healthy Adults
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00712803
Evaluating the Clinical and Immune Response to Two Dengue Virus Vaccines in Healthy Adults
National Institute of Allergy and Infectious Diseases (NIAID)
NCT02392325
ADVP005; Dengue CVD 12000 - Dengue-1-Virus Live Virus Human Challenge (DENV-1-LVHC)
University of Maryland, Baltimore
NCT04786457
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Dengue records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Dengue trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Dengue page
10 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Dengue trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- National Institute of Allergy and Infectious Diseases (NIAID) sponsors the most Dengue trials on record, review their full trial history before evaluating a specific study. See National Institute of Allergy and Infectious Diseases (NIAID)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Dengue condition card totals 10 registered trials; most-linked intervention Placebo; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.